R. Guo
Finance · with Lev · 2001–2009
A researcher in the Science corpus: 5 papers; trusts 19 researchers and is trusted by 5 researchers here, as inferred from the citation graph.
Subfields
- Finance — 54 citations into it
- Accounting — 44 citations into it; #5,025 of 8,970 by trust here, #2,906 by citations
- Economics and Econometrics — 21 citations into it; #14,441 of 23,481 by trust here, #9,060 by citations
- Strategy and Management — 17 citations into it
Whom R. Guo trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Halbert White
- Stephen H. Penman
- Alon Brav
- Lu Zhang
- Louis K. C. Chan
- Allan C. Eberhart
- Eugene F. Fama
- Baruch Lev
- Xiao-Jun Zhang
- J. Lewellen
Who trusts R. Guo overall
- Inderpal Singh
- Stephan Fuhrmann
- Baruch Lev
- John R. M. Hand
- J–L W. Mitchell Van der Zahn
- Xi Li
- Michael Dambra
- Christian Ott
- R. Duane Ireland
- J. Felício
Papers from R. Guo's perspective
Ordered by how strongly the researchers R. Guo trusts endorse each paper. Same corpus, a different order for every researcher.
- The Stock Market Valuation of Research and Development Expenditures
- Accounting Conservatism, the Quality of Earnings, and Stock Returns
- The Theory and Practice of Corporate Finance: Evidence from the Field
- The Value Premium
- Learning, Asset-Pricing Tests, and Market Efficiency
- A Heteroskedasticity-Consistent Covariance Matrix Estimator and a Direct Test for Heteroskedasticity
- Who Is My Peer? A Valuation-Based Approach to the Selection of Comparable Firms
- The Eyeballs Have It: Searching for the Value in Internet Stocks
- Why Don't Issuers Get Upset About Leaving Money on the Table in Ipos?
- Competitive Costs of Disclosure by Biotech IPOs
Their papers
- Competitive Costs of Disclosure by Biotech IPOs (2004) — 335 citations
- The Valuation of Biotech IPOs (2005) — 146 citations
- CAPM for Estimating the Cost of Equity Capital: Interpreting the Empirical Evidence (2009) — 202 citations
- Explaining the Short- and Long-Term IPO Anomalies in the US by R&D (2006) — 158 citations
- The option to withdraw IPOs during the premarket: empirical analysis (2001) — 190 citations